3,239 results on '"Blay, Jean-Yves"'
Search Results
2. Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants
3. EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers
4. A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
5. Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial.
6. Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial
7. Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study
8. Initial Active Surveillance Strategy for Patients with Peripheral Sporadic Primary Desmoid-Type Fibromatosis: A Multicentric Phase II Observational Trial
9. Artificial intelligence in oncology: ensuring safe and effective integration of language models in clinical practice
10. Discontinuation versus continuation of imatinib in patients with advanced gastrointestinal stromal tumours (BFR14): exploratory long-term follow-up of an open-label, multicentre, randomised, phase 3 trial
11. Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETO
12. Alveolar soft part sarcomas in young patients: The French national NETSARC+ network experience
13. Rethinking placebos: embracing synthetic control arms in clinical trials for rare tumors
14. Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial
15. Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy
16. The challenge of running trials in advanced angiosarcoma: A systematic review of the literature from EORTC/STBSG to guide the development of angiosarcoma-specific trials
17. Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
18. Enhanced accuracy and reduced delay in diagnosing bone tumors within an expert sarcoma network: A nationwide study
19. What is the optimal (neo)adjuvant strategy of extremity high-risk soft tissue sarcomas (ESTS)?
20. Radiotherapy in bone sarcoma: the quest for better treatment option
21. REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial
22. Deep learning predicts patients outcome and mutations from digitized histology slides in gastrointestinal stromal tumor
23. The TLR3 L412F polymorphism prevents TLR3-mediated tumor cell death induction in pediatric sarcomas
24. Management and outcomes of adolescent and young adult sarcoma patients: results from the French nationwide database NETSARC
25. Radioligand therapies in cancer: mapping the educational landscape in Europe
26. Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial
27. Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN
28. Precision Oncology in Soft Tissue Sarcomas and Gastrointestinal Stromal Tumors
29. Early morning immune checkpoint blockade and overall survival of patients with metastatic cancer: An In-depth chronotherapeutic study
30. Impact of guideline adherence and expert center referral on the early management and outcomes of uterine sarcoma patients: A retrospective analysis from the French NETSARC network
31. Rapport 23-22. Médicaments anti cancéreux onéreux : Disponibilité et soutenabilité économique
32. ASO Visual Abstract: Initial Active Surveillance Strategy for Patients with Peripheral Sporadic Primary Desmoid-Type Fibromatosis: A Multicentric Phase II Observational Trial
33. Leiomyosarcoma and liposarcoma in young patients: The national netsarc+ network experience
34. Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study
35. Prognostic Factors for Local Recurrence after Cryoablation of Desmoid Tumors
36. Prognostic factors of the synovial sarcoma of the extremities: imaging does matter
37. Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
38. Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial
39. Sarcomes du stroma endométrial de bas grade : référentiels de prise en charge du GSF-GETO/NETSARC+ et du groupe TMRG
40. Adénosarcomes mullériens de l’utérus – référentiels de prise en charge du GSF-GETO/NETSARC+ et du groupe TMRG
41. Traitement par imatinib des tumeurs stromales gastro-intestinales, 20 ans après
42. Le traitement des résistances moléculaires et des sous types rares de GIST en 2023
43. Occupational asbestos exposure and survival among lung cancer patients
44. Regorafenib for the Treatment of Sarcoma
45. Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022
46. Prévention et prise en charge des thromboses associées au cancer: questions pratiques à propos de l’anticoagulation
47. Desmoid type fibromatosis in pediatric and young adults from French databases: Clinical characteristics and initial outcome according to age
48. L’oncologie intégrative : état des lieux et place d’une consultation dédiée dans un centre de lutte contre le cancer
49. Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours: Long-term follow-up of nilotinib in TGCT
50. New Drug Approvals for Sarcoma in the Last 5 Years
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.